Location
Contact usAbout Dow
Dow Biomedica is a market developer & distributor of in-vitro diagnostics products.
Through partnership with global leaders, we are introducing cutting-edge technology products to our customers.
| Cleveland Diagnostics Signs Distribution Agreement with Dow BioMedica to Bring Prostate Cancer Test, IsoPSA, to Korea | |
|---|---|
| by 운영자 | Date 2024-04-17 14:23:28 | 전체목록 |
CLEVELAND, April 13, 2024 Cleveland Diagnostics, a commercial-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers has signed a distribution agreement with Dow BioMedica, a trusted distributor of life science solutions for biotechnology, clinical research organizations, and universities. Under this agreement, Dow BioMedica will exclusively distribute Cleveland Diagnostics’ IsoPSA prostate cancer test in Korea.
다음글 : Do it Art 슬로건 공모전 시상식
